About Us
CogentSage Group
We have created a proprietary method and digital platform that produces the only personal and population data ecosystem built to optimize the networks that support health and well-being. Our platform has applications to multiple health conditions and non-health market verticals.
Our CogentSageQI division has selected the longevity market as its initial target in order to help seniors age-in-place and avoid disruptive family care and expensive - and increasingly unavailable - paid forms of senior care. We can help facilitate independent living, improve quality of life and reduce the economic impact of longevity on families, employers and health payers.
Bruce is an innovator and IT entrepreneur. He managed senior care for his parents and in-laws.
With more than 30 years in research, healthcare technology and informatics, he founded and led various companies to improve patient outcomes. In 1993, he founded Covalent Research Group (NASDAQ:CVGR) a contract clinical research company; it has since been sold. He led software development to support self-management of diseases by chronically-ill patients. His clients included Merck, Pfizer, AstraZeneca, Pepsi, GM and IMS Health. In 2015, he co-founded CogentQI, introducing a unique platform with applications across a broad spectrum of market verticals.
Glenna is a successful innovator, entrepreneur and business woman. Our approach has enabled her 92 year old Mother to remain independent in her home.
As a School Psychologist, her model of assuring education for children with special needs became today's Individual Education Plans (IEPs). Appointed by President Ronald Reagan, she was responsible for a $70B portfolio of US health agencies, created new rare disease, orphan drug, and organ transplant programs. At Merck & Co, Inc. she created global public policy operations. A Global VP, she nearly tripled sales to $1B in under three years. Her global strategy firm provided counsel to biopharmaceutical, government and patient-group leaders. She received the highest award in public health,The Surgeon General's Medallion by C.Everett Koop.
A successful three-time CEO.
He has experience in software, entertainment, publishing, biopharmaceuticals and engineering in the US, Europe, China and the Middle East. He is a General Partner in a private equity partnership and a venture capital company with substantial M&A experience. He is a member of the Board of Directors and Chair of the Audit Committee of Ideaonomics, Inc. (NASDAQ:IDEX) He is partner and CFO of CoActive Health Solutions, Inc., Entrepreneur-in-Residence at the Wharton Business School and Chair of the Board of the Independence Hall Association.
A successful operation and collaboration executive, John has a track record of driving drug development through unique partnerships. John and his family have managed serious auto-immune and chronic diseases, including oncologic malignancy.
He was Managing Partner of Kurtz Associates. Formerly, he was Senior Director of External Alliances for Janssen, Senior Vice President of Technical Operations, for Omnicare and Senior Director of Covance. John's expertise includes engaging partnerships to drive collaboration, innovation and delivery on products on time and on budget. At Janssen, he was responsible for clinical trial and adverse-event reporting in pediatric asthma and allergy studies, for which his team built a HIPAA-compliant data capture and management system across all forms of clinical data streams.
